EGFR and lung cancer: Three trials specifically examining EGFR (OMIM 211980)–positive non–small cell lung cancers were excluded because of the disproportionate distribution of EGFR variants in Asian female patients.8 Of these 330 eligible trials, 221 reported at least 1 race and ethnicity, representing 8309 patients (4198 men [50.5%]; median age, 59 years).